Arch Cardiovasc Dis 2021 Mar 29;114(3):187-196. Epub 2021 Jan 29.
FACT (an F-CRIN network), DHU-FIRE, Hôpital Bichat, AP-HP, 75018 Paris, France; Université Paris-Diderot, Sorbonne Paris Cité, 75013 Paris, France; Inserm U1148, 75877 Paris, France; NLHI, ICMS, Royal Brompton Hospital, Imperial College, SW3 6LY London, UK.
Background: Few data are available on procedural complications of percutaneous coronary intervention (PCI) in the setting of acute coronary syndrome in the contemporary era.
Aim: We sought to describe the prevalence of procedural complications of PCI in a non-ST-segment elevation acute coronary syndrome (NSTE ACS) cohort, and to identify their clinical characteristics and association with clinical outcomes.
Methods: Patients randomized in TAO (Treatment of Acute coronary syndrome with Otamixaban), an international randomized controlled trial (ClinicalTrials. Read More